| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $34.2M | +77.6% |
| R&D Expense | $109.7M | +3.9% |
| SG&A Expense | $32.4M | +5.3% |
| Operating Income | -$107.9M | +7.9% |
| Pre-tax Income | -$94.2M | +13.5% |
| Income Tax | $4.2M | — |
| Net Income | -$98.4M | +9.6% |
| EPS (Basic) | -$2.34 | +10.7% |
| EPS (Diluted) | -$2.34 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $80.3M | +53.9% |
| Current Assets | $240.2M | -31.7% |
| Total Assets | $285.9M | -29.4% |
| Current Liabilities | $58.4M | +5.9% |
| Total Liabilities | $363.1M | -10.3% |
| Stockholders' Equity | -$77.2M | — |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$118.1M | -161.0% |
| Capital Expenditures | $1.2M | +1.2% |
| Investing Cash Flow | $144.4M | +159.1% |
| Financing Cash Flow | $1.8M | +0.9% |
| Free Cash Flow | -$119.3M | -162.0% |
| +10.7% |